Blood test may spot lung cancer without a needle biopsy

NCT ID NCT06838806

Recruiting now Diagnosis Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test called Nu.Q to see if it can accurately tell the difference between harmless and cancerous lung nodules. Researchers will collect blood from 500 people who have lung nodules found on CT scans and compare the test results with the final diagnosis from biopsy or surgery. If the blood test works well, it could reduce the need for invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nu.Q blood test (measures epigenetically modified nucleosomes)
What this could lead to: If successful, this blood test could help doctors quickly tell if a lung nodule is cancer without needing a biopsy or surgery.
What could go wrong: This is an early diagnostic study, not a treatment trial. The test may not be accurate enough to replace current methods, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG NODULE

Contacts and locations

Locations

National Taiwan University
RECRUITING

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.